Global Lung Cancer Liquid Biops Market Research Report 2025(Status and Outlook)
Report Overview
Liquid biopsy for lung cancer is a non-invasive diagnostic test that involves analyzing biomarkers, such as circulating tumor cells, cell-free DNA, and exosomes, in a patient's blood sample to detect and monitor the presence of lung cancer. This innovative approach provides a less invasive alternative to traditional tissue biopsies and enables healthcare providers to obtain real-time information about the genetic mutations and progression of the disease. By leveraging advanced technologies such as next-generation sequencing and digital PCR, liquid biopsy offers a promising tool for personalized medicine in the field of lung cancer treatment.
The market for lung cancer liquid biopsy is experiencing significant growth driven by several key factors. Firstly, the rising incidence of lung cancer worldwide, particularly in developing countries, is fueling the demand for non-invasive and accurate diagnostic tools. Liquid biopsy offers a convenient and less painful alternative to tissue biopsies, making it an attractive option for both patients and healthcare providers. Secondly, advancements in technology have enhanced the sensitivity and specificity of liquid biopsy tests, enabling early detection of lung cancer and monitoring of treatment response. Additionally, the growing emphasis on precision medicine and targeted therapies in oncology is driving the adoption of liquid biopsy as a tool for identifying actionable mutations and guiding treatment decisions.
Furthermore, the increasing investments in research and development by biotechnology and pharmaceutical companies, as well as government initiatives to promote cancer screening and early detection, are expected to further propel the growth of the lung cancer liquid biopsy market. With ongoing innovations in biomarker discovery, assay development, and data analysis, liquid biopsy is poised to revolutionize the field of oncology by offering a non-invasive, real-time, and personalized approach to diagnosing and managing lung cancer. As the technology continues to evolve and become more accessible, it is likely to become an integral part of routine clinical practice in the management of lung cancer patients.
This report provides a deep insight into the global Lung Cancer Liquid Biops market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Lung Cancer Liquid Biops Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Lung Cancer Liquid Biops market in any manner.
Global Lung Cancer Liquid Biops Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Biocept
EntroGen
Cynvenio Biosystems
Exosome Diagnostics
F. Hoffmann-La Roche
Clearbridge BioMedics
Bio-Rad Laboratories
Agena Bioscience
Cancer Genetics
CellMax Life
Nateras
MedGenome
OncoDNA
Genomic Health
Trovagene
Fluxion Biosciences
Biodesix
Epic Sciences
Shuwen Biotech
Personal Genome Diagnostics
Predicine
Market Segmentation (by Type)
Exosomes and RNA
CTCs and ctDNA
Market Segmentation (by Application)
Hospitals and Clinics
Physicians'Office Laboratories
Clinical Diagnostic Laboratories
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Lung Cancer Liquid Biops Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Liquid biopsy for lung cancer is a non-invasive diagnostic test that involves analyzing biomarkers, such as circulating tumor cells, cell-free DNA, and exosomes, in a patient's blood sample to detect and monitor the presence of lung cancer. This innovative approach provides a less invasive alternative to traditional tissue biopsies and enables healthcare providers to obtain real-time information about the genetic mutations and progression of the disease. By leveraging advanced technologies such as next-generation sequencing and digital PCR, liquid biopsy offers a promising tool for personalized medicine in the field of lung cancer treatment.
The market for lung cancer liquid biopsy is experiencing significant growth driven by several key factors. Firstly, the rising incidence of lung cancer worldwide, particularly in developing countries, is fueling the demand for non-invasive and accurate diagnostic tools. Liquid biopsy offers a convenient and less painful alternative to tissue biopsies, making it an attractive option for both patients and healthcare providers. Secondly, advancements in technology have enhanced the sensitivity and specificity of liquid biopsy tests, enabling early detection of lung cancer and monitoring of treatment response. Additionally, the growing emphasis on precision medicine and targeted therapies in oncology is driving the adoption of liquid biopsy as a tool for identifying actionable mutations and guiding treatment decisions.
Furthermore, the increasing investments in research and development by biotechnology and pharmaceutical companies, as well as government initiatives to promote cancer screening and early detection, are expected to further propel the growth of the lung cancer liquid biopsy market. With ongoing innovations in biomarker discovery, assay development, and data analysis, liquid biopsy is poised to revolutionize the field of oncology by offering a non-invasive, real-time, and personalized approach to diagnosing and managing lung cancer. As the technology continues to evolve and become more accessible, it is likely to become an integral part of routine clinical practice in the management of lung cancer patients.
This report provides a deep insight into the global Lung Cancer Liquid Biops market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Lung Cancer Liquid Biops Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Lung Cancer Liquid Biops market in any manner.
Global Lung Cancer Liquid Biops Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Biocept
EntroGen
Cynvenio Biosystems
Exosome Diagnostics
F. Hoffmann-La Roche
Clearbridge BioMedics
Bio-Rad Laboratories
Agena Bioscience
Cancer Genetics
CellMax Life
Nateras
MedGenome
OncoDNA
Genomic Health
Trovagene
Fluxion Biosciences
Biodesix
Epic Sciences
Shuwen Biotech
Personal Genome Diagnostics
Predicine
Market Segmentation (by Type)
Exosomes and RNA
CTCs and ctDNA
Market Segmentation (by Application)
Hospitals and Clinics
Physicians'Office Laboratories
Clinical Diagnostic Laboratories
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Lung Cancer Liquid Biops Market
- Overview of the regional outlook of the Lung Cancer Liquid Biops Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Lung Cancer Liquid Biops Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Lung Cancer Liquid Biops
1.2 Key Market Segments
1.2.1 Lung Cancer Liquid Biops Segment by Type
1.2.2 Lung Cancer Liquid Biops Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LUNG CANCER LIQUID BIOPS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Lung Cancer Liquid Biops Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Lung Cancer Liquid Biops Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LUNG CANCER LIQUID BIOPS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Lung Cancer Liquid Biops Product Life Cycle
3.3 Global Lung Cancer Liquid Biops Sales by Manufacturers (2020-2025)
3.4 Global Lung Cancer Liquid Biops Revenue Market Share by Manufacturers (2020-2025)
3.5 Lung Cancer Liquid Biops Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Lung Cancer Liquid Biops Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Lung Cancer Liquid Biops Sales Sites, Area Served, Product Type
3.8 Lung Cancer Liquid Biops Market Competitive Situation and Trends
3.8.1 Lung Cancer Liquid Biops Market Concentration Rate
3.8.2 Global 5 and 10 Largest Lung Cancer Liquid Biops Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 LUNG CANCER LIQUID BIOPS INDUSTRY CHAIN ANALYSIS
4.1 Lung Cancer Liquid Biops Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LUNG CANCER LIQUID BIOPS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 PEST Analysis
5.6.1 Industry Policies Analysis
5.6.2 Economic Environment Analysis
5.6.3 Social Environment Analysis
5.6.4 Technological Environment Analysis
5.7 Global Lung Cancer Liquid Biops Market Porter's Five Forces Analysis
5.7.1 Global Trade Frictions
5.7.2 Global Trade Frictions and Their Impacts to Lung Cancer Liquid Biops Market
5.8 ESG Ratings of Leading Companies
6 LUNG CANCER LIQUID BIOPS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lung Cancer Liquid Biops Sales Market Share by Type (2020-2025)
6.3 Global Lung Cancer Liquid Biops Market Size Market Share by Type (2020-2025)
6.4 Global Lung Cancer Liquid Biops Price by Type (2020-2025)
7 LUNG CANCER LIQUID BIOPS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lung Cancer Liquid Biops Market Sales by Application (2020-2025)
7.3 Global Lung Cancer Liquid Biops Market Size (M USD) by Application (2020-2025)
7.4 Global Lung Cancer Liquid Biops Sales Growth Rate by Application (2020-2025)
8 LUNG CANCER LIQUID BIOPS MARKET SALES BY REGION
8.1 Global Lung Cancer Liquid Biops Sales by Region
8.1.1 Global Lung Cancer Liquid Biops Sales by Region
8.1.2 Global Lung Cancer Liquid Biops Sales Market Share by Region
8.2 Global Lung Cancer Liquid Biops Market Size by Region
8.2.1 Global Lung Cancer Liquid Biops Market Size by Region
8.2.2 Global Lung Cancer Liquid Biops Market Size Market Share by Region
8.3 North America
8.3.1 North America Lung Cancer Liquid Biops Sales by Country
8.3.2 North America Lung Cancer Liquid Biops Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Lung Cancer Liquid Biops Sales by Country
8.4.2 Europe Lung Cancer Liquid Biops Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Lung Cancer Liquid Biops Sales by Region
8.5.2 Asia Pacific Lung Cancer Liquid Biops Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Lung Cancer Liquid Biops Sales by Country
8.6.2 South America Lung Cancer Liquid Biops Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Lung Cancer Liquid Biops Sales by Region
8.7.2 Middle East and Africa Lung Cancer Liquid Biops Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 LUNG CANCER LIQUID BIOPS MARKET PRODUCTION BY REGION
9.1 Global Production of Lung Cancer Liquid Biops by Region(2020-2025)
9.2 Global Lung Cancer Liquid Biops Revenue Market Share by Region (2020-2025)
9.3 Global Lung Cancer Liquid Biops Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Lung Cancer Liquid Biops Production
9.4.1 North America Lung Cancer Liquid Biops Production Growth Rate (2020-2025)
9.4.2 North America Lung Cancer Liquid Biops Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Lung Cancer Liquid Biops Production
9.5.1 Europe Lung Cancer Liquid Biops Production Growth Rate (2020-2025)
9.5.2 Europe Lung Cancer Liquid Biops Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Lung Cancer Liquid Biops Production (2020-2025)
9.6.1 Japan Lung Cancer Liquid Biops Production Growth Rate (2020-2025)
9.6.2 Japan Lung Cancer Liquid Biops Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Lung Cancer Liquid Biops Production (2020-2025)
9.7.1 China Lung Cancer Liquid Biops Production Growth Rate (2020-2025)
9.7.2 China Lung Cancer Liquid Biops Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Biocept
10.1.1 Biocept Basic Information
10.1.2 Biocept Lung Cancer Liquid Biops Product Overview
10.1.3 Biocept Lung Cancer Liquid Biops Product Market Performance
10.1.4 Biocept Business Overview
10.1.5 Biocept SWOT Analysis
10.1.6 Biocept Recent Developments
10.2 EntroGen
10.2.1 EntroGen Basic Information
10.2.2 EntroGen Lung Cancer Liquid Biops Product Overview
10.2.3 EntroGen Lung Cancer Liquid Biops Product Market Performance
10.2.4 EntroGen Business Overview
10.2.5 EntroGen SWOT Analysis
10.2.6 EntroGen Recent Developments
10.3 Cynvenio Biosystems
10.3.1 Cynvenio Biosystems Basic Information
10.3.2 Cynvenio Biosystems Lung Cancer Liquid Biops Product Overview
10.3.3 Cynvenio Biosystems Lung Cancer Liquid Biops Product Market Performance
10.3.4 Cynvenio Biosystems Business Overview
10.3.5 Cynvenio Biosystems SWOT Analysis
10.3.6 Cynvenio Biosystems Recent Developments
10.4 Exosome Diagnostics
10.4.1 Exosome Diagnostics Basic Information
10.4.2 Exosome Diagnostics Lung Cancer Liquid Biops Product Overview
10.4.3 Exosome Diagnostics Lung Cancer Liquid Biops Product Market Performance
10.4.4 Exosome Diagnostics Business Overview
10.4.5 Exosome Diagnostics Recent Developments
10.5 F. Hoffmann-La Roche
10.5.1 F. Hoffmann-La Roche Basic Information
10.5.2 F. Hoffmann-La Roche Lung Cancer Liquid Biops Product Overview
10.5.3 F. Hoffmann-La Roche Lung Cancer Liquid Biops Product Market Performance
10.5.4 F. Hoffmann-La Roche Business Overview
10.5.5 F. Hoffmann-La Roche Recent Developments
10.6 Clearbridge BioMedics
10.6.1 Clearbridge BioMedics Basic Information
10.6.2 Clearbridge BioMedics Lung Cancer Liquid Biops Product Overview
10.6.3 Clearbridge BioMedics Lung Cancer Liquid Biops Product Market Performance
10.6.4 Clearbridge BioMedics Business Overview
10.6.5 Clearbridge BioMedics Recent Developments
10.7 Bio-Rad Laboratories
10.7.1 Bio-Rad Laboratories Basic Information
10.7.2 Bio-Rad Laboratories Lung Cancer Liquid Biops Product Overview
10.7.3 Bio-Rad Laboratories Lung Cancer Liquid Biops Product Market Performance
10.7.4 Bio-Rad Laboratories Business Overview
10.7.5 Bio-Rad Laboratories Recent Developments
10.8 Agena Bioscience
10.8.1 Agena Bioscience Basic Information
10.8.2 Agena Bioscience Lung Cancer Liquid Biops Product Overview
10.8.3 Agena Bioscience Lung Cancer Liquid Biops Product Market Performance
10.8.4 Agena Bioscience Business Overview
10.8.5 Agena Bioscience Recent Developments
10.9 Cancer Genetics
10.9.1 Cancer Genetics Basic Information
10.9.2 Cancer Genetics Lung Cancer Liquid Biops Product Overview
10.9.3 Cancer Genetics Lung Cancer Liquid Biops Product Market Performance
10.9.4 Cancer Genetics Business Overview
10.9.5 Cancer Genetics Recent Developments
10.10 CellMax Life
10.10.1 CellMax Life Basic Information
10.10.2 CellMax Life Lung Cancer Liquid Biops Product Overview
10.10.3 CellMax Life Lung Cancer Liquid Biops Product Market Performance
10.10.4 CellMax Life Business Overview
10.10.5 CellMax Life Recent Developments
10.11 Nateras
10.11.1 Nateras Basic Information
10.11.2 Nateras Lung Cancer Liquid Biops Product Overview
10.11.3 Nateras Lung Cancer Liquid Biops Product Market Performance
10.11.4 Nateras Business Overview
10.11.5 Nateras Recent Developments
10.12 MedGenome
10.12.1 MedGenome Basic Information
10.12.2 MedGenome Lung Cancer Liquid Biops Product Overview
10.12.3 MedGenome Lung Cancer Liquid Biops Product Market Performance
10.12.4 MedGenome Business Overview
10.12.5 MedGenome Recent Developments
10.13 OncoDNA
10.13.1 OncoDNA Basic Information
10.13.2 OncoDNA Lung Cancer Liquid Biops Product Overview
10.13.3 OncoDNA Lung Cancer Liquid Biops Product Market Performance
10.13.4 OncoDNA Business Overview
10.13.5 OncoDNA Recent Developments
10.14 Genomic Health
10.14.1 Genomic Health Basic Information
10.14.2 Genomic Health Lung Cancer Liquid Biops Product Overview
10.14.3 Genomic Health Lung Cancer Liquid Biops Product Market Performance
10.14.4 Genomic Health Business Overview
10.14.5 Genomic Health Recent Developments
10.15 Trovagene
10.15.1 Trovagene Basic Information
10.15.2 Trovagene Lung Cancer Liquid Biops Product Overview
10.15.3 Trovagene Lung Cancer Liquid Biops Product Market Performance
10.15.4 Trovagene Business Overview
10.15.5 Trovagene Recent Developments
10.16 Fluxion Biosciences
10.16.1 Fluxion Biosciences Basic Information
10.16.2 Fluxion Biosciences Lung Cancer Liquid Biops Product Overview
10.16.3 Fluxion Biosciences Lung Cancer Liquid Biops Product Market Performance
10.16.4 Fluxion Biosciences Business Overview
10.16.5 Fluxion Biosciences Recent Developments
10.17 Biodesix
10.17.1 Biodesix Basic Information
10.17.2 Biodesix Lung Cancer Liquid Biops Product Overview
10.17.3 Biodesix Lung Cancer Liquid Biops Product Market Performance
10.17.4 Biodesix Business Overview
10.17.5 Biodesix Recent Developments
10.18 Epic Sciences
10.18.1 Epic Sciences Basic Information
10.18.2 Epic Sciences Lung Cancer Liquid Biops Product Overview
10.18.3 Epic Sciences Lung Cancer Liquid Biops Product Market Performance
10.18.4 Epic Sciences Business Overview
10.18.5 Epic Sciences Recent Developments
10.19 Shuwen Biotech
10.19.1 Shuwen Biotech Basic Information
10.19.2 Shuwen Biotech Lung Cancer Liquid Biops Product Overview
10.19.3 Shuwen Biotech Lung Cancer Liquid Biops Product Market Performance
10.19.4 Shuwen Biotech Business Overview
10.19.5 Shuwen Biotech Recent Developments
10.20 Personal Genome Diagnostics
10.20.1 Personal Genome Diagnostics Basic Information
10.20.2 Personal Genome Diagnostics Lung Cancer Liquid Biops Product Overview
10.20.3 Personal Genome Diagnostics Lung Cancer Liquid Biops Product Market Performance
10.20.4 Personal Genome Diagnostics Business Overview
10.20.5 Personal Genome Diagnostics Recent Developments
10.21 Predicine
10.21.1 Predicine Basic Information
10.21.2 Predicine Lung Cancer Liquid Biops Product Overview
10.21.3 Predicine Lung Cancer Liquid Biops Product Market Performance
10.21.4 Predicine Business Overview
10.21.5 Predicine Recent Developments
11 LUNG CANCER LIQUID BIOPS MARKET FORECAST BY REGION
11.1 Global Lung Cancer Liquid Biops Market Size Forecast
11.2 Global Lung Cancer Liquid Biops Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Lung Cancer Liquid Biops Market Size Forecast by Country
11.2.3 Asia Pacific Lung Cancer Liquid Biops Market Size Forecast by Region
11.2.4 South America Lung Cancer Liquid Biops Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Lung Cancer Liquid Biops by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Lung Cancer Liquid Biops Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Lung Cancer Liquid Biops by Type (2026-2033)
12.1.2 Global Lung Cancer Liquid Biops Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Lung Cancer Liquid Biops by Type (2026-2033)
12.2 Global Lung Cancer Liquid Biops Market Forecast by Application (2026-2033)
12.2.1 Global Lung Cancer Liquid Biops Sales (K Units) Forecast by Application
12.2.2 Global Lung Cancer Liquid Biops Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Lung Cancer Liquid Biops
1.2 Key Market Segments
1.2.1 Lung Cancer Liquid Biops Segment by Type
1.2.2 Lung Cancer Liquid Biops Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LUNG CANCER LIQUID BIOPS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Lung Cancer Liquid Biops Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Lung Cancer Liquid Biops Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LUNG CANCER LIQUID BIOPS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Lung Cancer Liquid Biops Product Life Cycle
3.3 Global Lung Cancer Liquid Biops Sales by Manufacturers (2020-2025)
3.4 Global Lung Cancer Liquid Biops Revenue Market Share by Manufacturers (2020-2025)
3.5 Lung Cancer Liquid Biops Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Lung Cancer Liquid Biops Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Lung Cancer Liquid Biops Sales Sites, Area Served, Product Type
3.8 Lung Cancer Liquid Biops Market Competitive Situation and Trends
3.8.1 Lung Cancer Liquid Biops Market Concentration Rate
3.8.2 Global 5 and 10 Largest Lung Cancer Liquid Biops Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 LUNG CANCER LIQUID BIOPS INDUSTRY CHAIN ANALYSIS
4.1 Lung Cancer Liquid Biops Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LUNG CANCER LIQUID BIOPS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 PEST Analysis
5.6.1 Industry Policies Analysis
5.6.2 Economic Environment Analysis
5.6.3 Social Environment Analysis
5.6.4 Technological Environment Analysis
5.7 Global Lung Cancer Liquid Biops Market Porter's Five Forces Analysis
5.7.1 Global Trade Frictions
5.7.2 Global Trade Frictions and Their Impacts to Lung Cancer Liquid Biops Market
5.8 ESG Ratings of Leading Companies
6 LUNG CANCER LIQUID BIOPS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Lung Cancer Liquid Biops Sales Market Share by Type (2020-2025)
6.3 Global Lung Cancer Liquid Biops Market Size Market Share by Type (2020-2025)
6.4 Global Lung Cancer Liquid Biops Price by Type (2020-2025)
7 LUNG CANCER LIQUID BIOPS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Lung Cancer Liquid Biops Market Sales by Application (2020-2025)
7.3 Global Lung Cancer Liquid Biops Market Size (M USD) by Application (2020-2025)
7.4 Global Lung Cancer Liquid Biops Sales Growth Rate by Application (2020-2025)
8 LUNG CANCER LIQUID BIOPS MARKET SALES BY REGION
8.1 Global Lung Cancer Liquid Biops Sales by Region
8.1.1 Global Lung Cancer Liquid Biops Sales by Region
8.1.2 Global Lung Cancer Liquid Biops Sales Market Share by Region
8.2 Global Lung Cancer Liquid Biops Market Size by Region
8.2.1 Global Lung Cancer Liquid Biops Market Size by Region
8.2.2 Global Lung Cancer Liquid Biops Market Size Market Share by Region
8.3 North America
8.3.1 North America Lung Cancer Liquid Biops Sales by Country
8.3.2 North America Lung Cancer Liquid Biops Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Lung Cancer Liquid Biops Sales by Country
8.4.2 Europe Lung Cancer Liquid Biops Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Lung Cancer Liquid Biops Sales by Region
8.5.2 Asia Pacific Lung Cancer Liquid Biops Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Lung Cancer Liquid Biops Sales by Country
8.6.2 South America Lung Cancer Liquid Biops Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Lung Cancer Liquid Biops Sales by Region
8.7.2 Middle East and Africa Lung Cancer Liquid Biops Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 LUNG CANCER LIQUID BIOPS MARKET PRODUCTION BY REGION
9.1 Global Production of Lung Cancer Liquid Biops by Region(2020-2025)
9.2 Global Lung Cancer Liquid Biops Revenue Market Share by Region (2020-2025)
9.3 Global Lung Cancer Liquid Biops Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Lung Cancer Liquid Biops Production
9.4.1 North America Lung Cancer Liquid Biops Production Growth Rate (2020-2025)
9.4.2 North America Lung Cancer Liquid Biops Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Lung Cancer Liquid Biops Production
9.5.1 Europe Lung Cancer Liquid Biops Production Growth Rate (2020-2025)
9.5.2 Europe Lung Cancer Liquid Biops Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Lung Cancer Liquid Biops Production (2020-2025)
9.6.1 Japan Lung Cancer Liquid Biops Production Growth Rate (2020-2025)
9.6.2 Japan Lung Cancer Liquid Biops Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Lung Cancer Liquid Biops Production (2020-2025)
9.7.1 China Lung Cancer Liquid Biops Production Growth Rate (2020-2025)
9.7.2 China Lung Cancer Liquid Biops Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Biocept
10.1.1 Biocept Basic Information
10.1.2 Biocept Lung Cancer Liquid Biops Product Overview
10.1.3 Biocept Lung Cancer Liquid Biops Product Market Performance
10.1.4 Biocept Business Overview
10.1.5 Biocept SWOT Analysis
10.1.6 Biocept Recent Developments
10.2 EntroGen
10.2.1 EntroGen Basic Information
10.2.2 EntroGen Lung Cancer Liquid Biops Product Overview
10.2.3 EntroGen Lung Cancer Liquid Biops Product Market Performance
10.2.4 EntroGen Business Overview
10.2.5 EntroGen SWOT Analysis
10.2.6 EntroGen Recent Developments
10.3 Cynvenio Biosystems
10.3.1 Cynvenio Biosystems Basic Information
10.3.2 Cynvenio Biosystems Lung Cancer Liquid Biops Product Overview
10.3.3 Cynvenio Biosystems Lung Cancer Liquid Biops Product Market Performance
10.3.4 Cynvenio Biosystems Business Overview
10.3.5 Cynvenio Biosystems SWOT Analysis
10.3.6 Cynvenio Biosystems Recent Developments
10.4 Exosome Diagnostics
10.4.1 Exosome Diagnostics Basic Information
10.4.2 Exosome Diagnostics Lung Cancer Liquid Biops Product Overview
10.4.3 Exosome Diagnostics Lung Cancer Liquid Biops Product Market Performance
10.4.4 Exosome Diagnostics Business Overview
10.4.5 Exosome Diagnostics Recent Developments
10.5 F. Hoffmann-La Roche
10.5.1 F. Hoffmann-La Roche Basic Information
10.5.2 F. Hoffmann-La Roche Lung Cancer Liquid Biops Product Overview
10.5.3 F. Hoffmann-La Roche Lung Cancer Liquid Biops Product Market Performance
10.5.4 F. Hoffmann-La Roche Business Overview
10.5.5 F. Hoffmann-La Roche Recent Developments
10.6 Clearbridge BioMedics
10.6.1 Clearbridge BioMedics Basic Information
10.6.2 Clearbridge BioMedics Lung Cancer Liquid Biops Product Overview
10.6.3 Clearbridge BioMedics Lung Cancer Liquid Biops Product Market Performance
10.6.4 Clearbridge BioMedics Business Overview
10.6.5 Clearbridge BioMedics Recent Developments
10.7 Bio-Rad Laboratories
10.7.1 Bio-Rad Laboratories Basic Information
10.7.2 Bio-Rad Laboratories Lung Cancer Liquid Biops Product Overview
10.7.3 Bio-Rad Laboratories Lung Cancer Liquid Biops Product Market Performance
10.7.4 Bio-Rad Laboratories Business Overview
10.7.5 Bio-Rad Laboratories Recent Developments
10.8 Agena Bioscience
10.8.1 Agena Bioscience Basic Information
10.8.2 Agena Bioscience Lung Cancer Liquid Biops Product Overview
10.8.3 Agena Bioscience Lung Cancer Liquid Biops Product Market Performance
10.8.4 Agena Bioscience Business Overview
10.8.5 Agena Bioscience Recent Developments
10.9 Cancer Genetics
10.9.1 Cancer Genetics Basic Information
10.9.2 Cancer Genetics Lung Cancer Liquid Biops Product Overview
10.9.3 Cancer Genetics Lung Cancer Liquid Biops Product Market Performance
10.9.4 Cancer Genetics Business Overview
10.9.5 Cancer Genetics Recent Developments
10.10 CellMax Life
10.10.1 CellMax Life Basic Information
10.10.2 CellMax Life Lung Cancer Liquid Biops Product Overview
10.10.3 CellMax Life Lung Cancer Liquid Biops Product Market Performance
10.10.4 CellMax Life Business Overview
10.10.5 CellMax Life Recent Developments
10.11 Nateras
10.11.1 Nateras Basic Information
10.11.2 Nateras Lung Cancer Liquid Biops Product Overview
10.11.3 Nateras Lung Cancer Liquid Biops Product Market Performance
10.11.4 Nateras Business Overview
10.11.5 Nateras Recent Developments
10.12 MedGenome
10.12.1 MedGenome Basic Information
10.12.2 MedGenome Lung Cancer Liquid Biops Product Overview
10.12.3 MedGenome Lung Cancer Liquid Biops Product Market Performance
10.12.4 MedGenome Business Overview
10.12.5 MedGenome Recent Developments
10.13 OncoDNA
10.13.1 OncoDNA Basic Information
10.13.2 OncoDNA Lung Cancer Liquid Biops Product Overview
10.13.3 OncoDNA Lung Cancer Liquid Biops Product Market Performance
10.13.4 OncoDNA Business Overview
10.13.5 OncoDNA Recent Developments
10.14 Genomic Health
10.14.1 Genomic Health Basic Information
10.14.2 Genomic Health Lung Cancer Liquid Biops Product Overview
10.14.3 Genomic Health Lung Cancer Liquid Biops Product Market Performance
10.14.4 Genomic Health Business Overview
10.14.5 Genomic Health Recent Developments
10.15 Trovagene
10.15.1 Trovagene Basic Information
10.15.2 Trovagene Lung Cancer Liquid Biops Product Overview
10.15.3 Trovagene Lung Cancer Liquid Biops Product Market Performance
10.15.4 Trovagene Business Overview
10.15.5 Trovagene Recent Developments
10.16 Fluxion Biosciences
10.16.1 Fluxion Biosciences Basic Information
10.16.2 Fluxion Biosciences Lung Cancer Liquid Biops Product Overview
10.16.3 Fluxion Biosciences Lung Cancer Liquid Biops Product Market Performance
10.16.4 Fluxion Biosciences Business Overview
10.16.5 Fluxion Biosciences Recent Developments
10.17 Biodesix
10.17.1 Biodesix Basic Information
10.17.2 Biodesix Lung Cancer Liquid Biops Product Overview
10.17.3 Biodesix Lung Cancer Liquid Biops Product Market Performance
10.17.4 Biodesix Business Overview
10.17.5 Biodesix Recent Developments
10.18 Epic Sciences
10.18.1 Epic Sciences Basic Information
10.18.2 Epic Sciences Lung Cancer Liquid Biops Product Overview
10.18.3 Epic Sciences Lung Cancer Liquid Biops Product Market Performance
10.18.4 Epic Sciences Business Overview
10.18.5 Epic Sciences Recent Developments
10.19 Shuwen Biotech
10.19.1 Shuwen Biotech Basic Information
10.19.2 Shuwen Biotech Lung Cancer Liquid Biops Product Overview
10.19.3 Shuwen Biotech Lung Cancer Liquid Biops Product Market Performance
10.19.4 Shuwen Biotech Business Overview
10.19.5 Shuwen Biotech Recent Developments
10.20 Personal Genome Diagnostics
10.20.1 Personal Genome Diagnostics Basic Information
10.20.2 Personal Genome Diagnostics Lung Cancer Liquid Biops Product Overview
10.20.3 Personal Genome Diagnostics Lung Cancer Liquid Biops Product Market Performance
10.20.4 Personal Genome Diagnostics Business Overview
10.20.5 Personal Genome Diagnostics Recent Developments
10.21 Predicine
10.21.1 Predicine Basic Information
10.21.2 Predicine Lung Cancer Liquid Biops Product Overview
10.21.3 Predicine Lung Cancer Liquid Biops Product Market Performance
10.21.4 Predicine Business Overview
10.21.5 Predicine Recent Developments
11 LUNG CANCER LIQUID BIOPS MARKET FORECAST BY REGION
11.1 Global Lung Cancer Liquid Biops Market Size Forecast
11.2 Global Lung Cancer Liquid Biops Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Lung Cancer Liquid Biops Market Size Forecast by Country
11.2.3 Asia Pacific Lung Cancer Liquid Biops Market Size Forecast by Region
11.2.4 South America Lung Cancer Liquid Biops Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Lung Cancer Liquid Biops by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Lung Cancer Liquid Biops Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Lung Cancer Liquid Biops by Type (2026-2033)
12.1.2 Global Lung Cancer Liquid Biops Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Lung Cancer Liquid Biops by Type (2026-2033)
12.2 Global Lung Cancer Liquid Biops Market Forecast by Application (2026-2033)
12.2.1 Global Lung Cancer Liquid Biops Sales (K Units) Forecast by Application
12.2.2 Global Lung Cancer Liquid Biops Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Lung Cancer Liquid Biops Market Size Comparison by Region (M USD)
Table 5. Global Lung Cancer Liquid Biops Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Lung Cancer Liquid Biops Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Lung Cancer Liquid Biops Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Lung Cancer Liquid Biops Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biops as of 2024)
Table 10. Global Market Lung Cancer Liquid Biops Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Lung Cancer Liquid Biops Sales Sites and Area Served
Table 12. Manufacturers Lung Cancer Liquid Biops Product Type
Table 13. Global Lung Cancer Liquid Biops Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Lung Cancer Liquid Biops Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Lung Cancer Liquid Biops Sales by Type (K Units)
Table 25. Global Lung Cancer Liquid Biops Market Size by Type (M USD)
Table 26. Global Lung Cancer Liquid Biops Sales (K Units) by Type (2020-2025)
Table 27. Global Lung Cancer Liquid Biops Sales Market Share by Type (2020-2025)
Table 28. Global Lung Cancer Liquid Biops Market Size (M USD) by Type (2020-2025)
Table 29. Global Lung Cancer Liquid Biops Market Size Share by Type (2020-2025)
Table 30. Global Lung Cancer Liquid Biops Price (USD/Unit) by Type (2020-2025)
Table 31. Global Lung Cancer Liquid Biops Sales (K Units) by Application
Table 32. Global Lung Cancer Liquid Biops Market Size by Application
Table 33. Global Lung Cancer Liquid Biops Sales by Application (2020-2025) & (K Units)
Table 34. Global Lung Cancer Liquid Biops Sales Market Share by Application (2020-2025)
Table 35. Global Lung Cancer Liquid Biops Market Size by Application (2020-2025) & (M USD)
Table 36. Global Lung Cancer Liquid Biops Market Share by Application (2020-2025)
Table 37. Global Lung Cancer Liquid Biops Sales Growth Rate by Application (2020-2025)
Table 38. Global Lung Cancer Liquid Biops Sales by Region (2020-2025) & (K Units)
Table 39. Global Lung Cancer Liquid Biops Sales Market Share by Region (2020-2025)
Table 40. Global Lung Cancer Liquid Biops Market Size by Region (2020-2025) & (M USD)
Table 41. Global Lung Cancer Liquid Biops Market Size Market Share by Region (2020-2025)
Table 42. North America Lung Cancer Liquid Biops Sales by Country (2020-2025) & (K Units)
Table 43. North America Lung Cancer Liquid Biops Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Lung Cancer Liquid Biops Sales by Country (2020-2025) & (K Units)
Table 45. Europe Lung Cancer Liquid Biops Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Lung Cancer Liquid Biops Sales by Region (2020-2025) & (K Units)
Table 47. Asia Pacific Lung Cancer Liquid Biops Market Size by Region (2020-2025) & (M USD)
Table 48. South America Lung Cancer Liquid Biops Sales by Country (2020-2025) & (K Units)
Table 49. South America Lung Cancer Liquid Biops Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Lung Cancer Liquid Biops Sales by Region (2020-2025) & (K Units)
Table 51. Middle East and Africa Lung Cancer Liquid Biops Market Size by Region (2020-2025) & (M USD)
Table 52. Global Lung Cancer Liquid Biops Production (K Units) by Region(2020-2025)
Table 53. Global Lung Cancer Liquid Biops Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Lung Cancer Liquid Biops Revenue Market Share by Region (2020-2025)
Table 55. Global Lung Cancer Liquid Biops Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. North America Lung Cancer Liquid Biops Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. Europe Lung Cancer Liquid Biops Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Japan Lung Cancer Liquid Biops Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. China Lung Cancer Liquid Biops Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Biocept Basic Information
Table 61. Biocept Lung Cancer Liquid Biops Product Overview
Table 62. Biocept Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. Biocept Business Overview
Table 64. Biocept SWOT Analysis
Table 65. Biocept Recent Developments
Table 66. EntroGen Basic Information
Table 67. EntroGen Lung Cancer Liquid Biops Product Overview
Table 68. EntroGen Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 69. EntroGen Business Overview
Table 70. EntroGen SWOT Analysis
Table 71. EntroGen Recent Developments
Table 72. Cynvenio Biosystems Basic Information
Table 73. Cynvenio Biosystems Lung Cancer Liquid Biops Product Overview
Table 74. Cynvenio Biosystems Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Cynvenio Biosystems Business Overview
Table 76. Cynvenio Biosystems SWOT Analysis
Table 77. Cynvenio Biosystems Recent Developments
Table 78. Exosome Diagnostics Basic Information
Table 79. Exosome Diagnostics Lung Cancer Liquid Biops Product Overview
Table 80. Exosome Diagnostics Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Exosome Diagnostics Business Overview
Table 82. Exosome Diagnostics Recent Developments
Table 83. F. Hoffmann-La Roche Basic Information
Table 84. F. Hoffmann-La Roche Lung Cancer Liquid Biops Product Overview
Table 85. F. Hoffmann-La Roche Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. F. Hoffmann-La Roche Business Overview
Table 87. F. Hoffmann-La Roche Recent Developments
Table 88. Clearbridge BioMedics Basic Information
Table 89. Clearbridge BioMedics Lung Cancer Liquid Biops Product Overview
Table 90. Clearbridge BioMedics Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Clearbridge BioMedics Business Overview
Table 92. Clearbridge BioMedics Recent Developments
Table 93. Bio-Rad Laboratories Basic Information
Table 94. Bio-Rad Laboratories Lung Cancer Liquid Biops Product Overview
Table 95. Bio-Rad Laboratories Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Bio-Rad Laboratories Business Overview
Table 97. Bio-Rad Laboratories Recent Developments
Table 98. Agena Bioscience Basic Information
Table 99. Agena Bioscience Lung Cancer Liquid Biops Product Overview
Table 100. Agena Bioscience Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Agena Bioscience Business Overview
Table 102. Agena Bioscience Recent Developments
Table 103. Cancer Genetics Basic Information
Table 104. Cancer Genetics Lung Cancer Liquid Biops Product Overview
Table 105. Cancer Genetics Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Cancer Genetics Business Overview
Table 107. Cancer Genetics Recent Developments
Table 108. CellMax Life Basic Information
Table 109. CellMax Life Lung Cancer Liquid Biops Product Overview
Table 110. CellMax Life Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. CellMax Life Business Overview
Table 112. CellMax Life Recent Developments
Table 113. Nateras Basic Information
Table 114. Nateras Lung Cancer Liquid Biops Product Overview
Table 115. Nateras Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Nateras Business Overview
Table 117. Nateras Recent Developments
Table 118. MedGenome Basic Information
Table 119. MedGenome Lung Cancer Liquid Biops Product Overview
Table 120. MedGenome Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. MedGenome Business Overview
Table 122. MedGenome Recent Developments
Table 123. OncoDNA Basic Information
Table 124. OncoDNA Lung Cancer Liquid Biops Product Overview
Table 125. OncoDNA Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126. OncoDNA Business Overview
Table 127. OncoDNA Recent Developments
Table 128. Genomic Health Basic Information
Table 129. Genomic Health Lung Cancer Liquid Biops Product Overview
Table 130. Genomic Health Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 131. Genomic Health Business Overview
Table 132. Genomic Health Recent Developments
Table 133. Trovagene Basic Information
Table 134. Trovagene Lung Cancer Liquid Biops Product Overview
Table 135. Trovagene Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 136. Trovagene Business Overview
Table 137. Trovagene Recent Developments
Table 138. Fluxion Biosciences Basic Information
Table 139. Fluxion Biosciences Lung Cancer Liquid Biops Product Overview
Table 140. Fluxion Biosciences Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 141. Fluxion Biosciences Business Overview
Table 142. Fluxion Biosciences Recent Developments
Table 143. Biodesix Basic Information
Table 144. Biodesix Lung Cancer Liquid Biops Product Overview
Table 145. Biodesix Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 146. Biodesix Business Overview
Table 147. Biodesix Recent Developments
Table 148. Epic Sciences Basic Information
Table 149. Epic Sciences Lung Cancer Liquid Biops Product Overview
Table 150. Epic Sciences Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 151. Epic Sciences Business Overview
Table 152. Epic Sciences Recent Developments
Table 153. Shuwen Biotech Basic Information
Table 154. Shuwen Biotech Lung Cancer Liquid Biops Product Overview
Table 155. Shuwen Biotech Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 156. Shuwen Biotech Business Overview
Table 157. Shuwen Biotech Recent Developments
Table 158. Personal Genome Diagnostics Basic Information
Table 159. Personal Genome Diagnostics Lung Cancer Liquid Biops Product Overview
Table 160. Personal Genome Diagnostics Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 161. Personal Genome Diagnostics Business Overview
Table 162. Personal Genome Diagnostics Recent Developments
Table 163. Predicine Basic Information
Table 164. Predicine Lung Cancer Liquid Biops Product Overview
Table 165. Predicine Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 166. Predicine Business Overview
Table 167. Predicine Recent Developments
Table 168. Global Lung Cancer Liquid Biops Sales Forecast by Region (2026-2033) & (K Units)
Table 169. Global Lung Cancer Liquid Biops Market Size Forecast by Region (2026-2033) & (M USD)
Table 170. North America Lung Cancer Liquid Biops Sales Forecast by Country (2026-2033) & (K Units)
Table 171. North America Lung Cancer Liquid Biops Market Size Forecast by Country (2026-2033) & (M USD)
Table 172. Europe Lung Cancer Liquid Biops Sales Forecast by Country (2026-2033) & (K Units)
Table 173. Europe Lung Cancer Liquid Biops Market Size Forecast by Country (2026-2033) & (M USD)
Table 174. Asia Pacific Lung Cancer Liquid Biops Sales Forecast by Region (2026-2033) & (K Units)
Table 175. Asia Pacific Lung Cancer Liquid Biops Market Size Forecast by Region (2026-2033) & (M USD)
Table 176. South America Lung Cancer Liquid Biops Sales Forecast by Country (2026-2033) & (K Units)
Table 177. South America Lung Cancer Liquid Biops Market Size Forecast by Country (2026-2033) & (M USD)
Table 178. Middle East and Africa Lung Cancer Liquid Biops Sales Forecast by Country (2026-2033) & (Units)
Table 179. Middle East and Africa Lung Cancer Liquid Biops Market Size Forecast by Country (2026-2033) & (M USD)
Table 180. Global Lung Cancer Liquid Biops Sales Forecast by Type (2026-2033) & (K Units)
Table 181. Global Lung Cancer Liquid Biops Market Size Forecast by Type (2026-2033) & (M USD)
Table 182. Global Lung Cancer Liquid Biops Price Forecast by Type (2026-2033) & (USD/Unit)
Table 183. Global Lung Cancer Liquid Biops Sales (K Units) Forecast by Application (2026-2033)
Table 184. Global Lung Cancer Liquid Biops Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Lung Cancer Liquid Biops Market Size Comparison by Region (M USD)
Table 5. Global Lung Cancer Liquid Biops Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Lung Cancer Liquid Biops Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Lung Cancer Liquid Biops Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Lung Cancer Liquid Biops Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Liquid Biops as of 2024)
Table 10. Global Market Lung Cancer Liquid Biops Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Lung Cancer Liquid Biops Sales Sites and Area Served
Table 12. Manufacturers Lung Cancer Liquid Biops Product Type
Table 13. Global Lung Cancer Liquid Biops Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Lung Cancer Liquid Biops Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Lung Cancer Liquid Biops Sales by Type (K Units)
Table 25. Global Lung Cancer Liquid Biops Market Size by Type (M USD)
Table 26. Global Lung Cancer Liquid Biops Sales (K Units) by Type (2020-2025)
Table 27. Global Lung Cancer Liquid Biops Sales Market Share by Type (2020-2025)
Table 28. Global Lung Cancer Liquid Biops Market Size (M USD) by Type (2020-2025)
Table 29. Global Lung Cancer Liquid Biops Market Size Share by Type (2020-2025)
Table 30. Global Lung Cancer Liquid Biops Price (USD/Unit) by Type (2020-2025)
Table 31. Global Lung Cancer Liquid Biops Sales (K Units) by Application
Table 32. Global Lung Cancer Liquid Biops Market Size by Application
Table 33. Global Lung Cancer Liquid Biops Sales by Application (2020-2025) & (K Units)
Table 34. Global Lung Cancer Liquid Biops Sales Market Share by Application (2020-2025)
Table 35. Global Lung Cancer Liquid Biops Market Size by Application (2020-2025) & (M USD)
Table 36. Global Lung Cancer Liquid Biops Market Share by Application (2020-2025)
Table 37. Global Lung Cancer Liquid Biops Sales Growth Rate by Application (2020-2025)
Table 38. Global Lung Cancer Liquid Biops Sales by Region (2020-2025) & (K Units)
Table 39. Global Lung Cancer Liquid Biops Sales Market Share by Region (2020-2025)
Table 40. Global Lung Cancer Liquid Biops Market Size by Region (2020-2025) & (M USD)
Table 41. Global Lung Cancer Liquid Biops Market Size Market Share by Region (2020-2025)
Table 42. North America Lung Cancer Liquid Biops Sales by Country (2020-2025) & (K Units)
Table 43. North America Lung Cancer Liquid Biops Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Lung Cancer Liquid Biops Sales by Country (2020-2025) & (K Units)
Table 45. Europe Lung Cancer Liquid Biops Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Lung Cancer Liquid Biops Sales by Region (2020-2025) & (K Units)
Table 47. Asia Pacific Lung Cancer Liquid Biops Market Size by Region (2020-2025) & (M USD)
Table 48. South America Lung Cancer Liquid Biops Sales by Country (2020-2025) & (K Units)
Table 49. South America Lung Cancer Liquid Biops Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Lung Cancer Liquid Biops Sales by Region (2020-2025) & (K Units)
Table 51. Middle East and Africa Lung Cancer Liquid Biops Market Size by Region (2020-2025) & (M USD)
Table 52. Global Lung Cancer Liquid Biops Production (K Units) by Region(2020-2025)
Table 53. Global Lung Cancer Liquid Biops Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Lung Cancer Liquid Biops Revenue Market Share by Region (2020-2025)
Table 55. Global Lung Cancer Liquid Biops Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. North America Lung Cancer Liquid Biops Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. Europe Lung Cancer Liquid Biops Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Japan Lung Cancer Liquid Biops Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. China Lung Cancer Liquid Biops Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Biocept Basic Information
Table 61. Biocept Lung Cancer Liquid Biops Product Overview
Table 62. Biocept Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. Biocept Business Overview
Table 64. Biocept SWOT Analysis
Table 65. Biocept Recent Developments
Table 66. EntroGen Basic Information
Table 67. EntroGen Lung Cancer Liquid Biops Product Overview
Table 68. EntroGen Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 69. EntroGen Business Overview
Table 70. EntroGen SWOT Analysis
Table 71. EntroGen Recent Developments
Table 72. Cynvenio Biosystems Basic Information
Table 73. Cynvenio Biosystems Lung Cancer Liquid Biops Product Overview
Table 74. Cynvenio Biosystems Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Cynvenio Biosystems Business Overview
Table 76. Cynvenio Biosystems SWOT Analysis
Table 77. Cynvenio Biosystems Recent Developments
Table 78. Exosome Diagnostics Basic Information
Table 79. Exosome Diagnostics Lung Cancer Liquid Biops Product Overview
Table 80. Exosome Diagnostics Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Exosome Diagnostics Business Overview
Table 82. Exosome Diagnostics Recent Developments
Table 83. F. Hoffmann-La Roche Basic Information
Table 84. F. Hoffmann-La Roche Lung Cancer Liquid Biops Product Overview
Table 85. F. Hoffmann-La Roche Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. F. Hoffmann-La Roche Business Overview
Table 87. F. Hoffmann-La Roche Recent Developments
Table 88. Clearbridge BioMedics Basic Information
Table 89. Clearbridge BioMedics Lung Cancer Liquid Biops Product Overview
Table 90. Clearbridge BioMedics Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Clearbridge BioMedics Business Overview
Table 92. Clearbridge BioMedics Recent Developments
Table 93. Bio-Rad Laboratories Basic Information
Table 94. Bio-Rad Laboratories Lung Cancer Liquid Biops Product Overview
Table 95. Bio-Rad Laboratories Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Bio-Rad Laboratories Business Overview
Table 97. Bio-Rad Laboratories Recent Developments
Table 98. Agena Bioscience Basic Information
Table 99. Agena Bioscience Lung Cancer Liquid Biops Product Overview
Table 100. Agena Bioscience Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Agena Bioscience Business Overview
Table 102. Agena Bioscience Recent Developments
Table 103. Cancer Genetics Basic Information
Table 104. Cancer Genetics Lung Cancer Liquid Biops Product Overview
Table 105. Cancer Genetics Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Cancer Genetics Business Overview
Table 107. Cancer Genetics Recent Developments
Table 108. CellMax Life Basic Information
Table 109. CellMax Life Lung Cancer Liquid Biops Product Overview
Table 110. CellMax Life Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. CellMax Life Business Overview
Table 112. CellMax Life Recent Developments
Table 113. Nateras Basic Information
Table 114. Nateras Lung Cancer Liquid Biops Product Overview
Table 115. Nateras Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Nateras Business Overview
Table 117. Nateras Recent Developments
Table 118. MedGenome Basic Information
Table 119. MedGenome Lung Cancer Liquid Biops Product Overview
Table 120. MedGenome Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. MedGenome Business Overview
Table 122. MedGenome Recent Developments
Table 123. OncoDNA Basic Information
Table 124. OncoDNA Lung Cancer Liquid Biops Product Overview
Table 125. OncoDNA Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126. OncoDNA Business Overview
Table 127. OncoDNA Recent Developments
Table 128. Genomic Health Basic Information
Table 129. Genomic Health Lung Cancer Liquid Biops Product Overview
Table 130. Genomic Health Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 131. Genomic Health Business Overview
Table 132. Genomic Health Recent Developments
Table 133. Trovagene Basic Information
Table 134. Trovagene Lung Cancer Liquid Biops Product Overview
Table 135. Trovagene Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 136. Trovagene Business Overview
Table 137. Trovagene Recent Developments
Table 138. Fluxion Biosciences Basic Information
Table 139. Fluxion Biosciences Lung Cancer Liquid Biops Product Overview
Table 140. Fluxion Biosciences Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 141. Fluxion Biosciences Business Overview
Table 142. Fluxion Biosciences Recent Developments
Table 143. Biodesix Basic Information
Table 144. Biodesix Lung Cancer Liquid Biops Product Overview
Table 145. Biodesix Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 146. Biodesix Business Overview
Table 147. Biodesix Recent Developments
Table 148. Epic Sciences Basic Information
Table 149. Epic Sciences Lung Cancer Liquid Biops Product Overview
Table 150. Epic Sciences Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 151. Epic Sciences Business Overview
Table 152. Epic Sciences Recent Developments
Table 153. Shuwen Biotech Basic Information
Table 154. Shuwen Biotech Lung Cancer Liquid Biops Product Overview
Table 155. Shuwen Biotech Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 156. Shuwen Biotech Business Overview
Table 157. Shuwen Biotech Recent Developments
Table 158. Personal Genome Diagnostics Basic Information
Table 159. Personal Genome Diagnostics Lung Cancer Liquid Biops Product Overview
Table 160. Personal Genome Diagnostics Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 161. Personal Genome Diagnostics Business Overview
Table 162. Personal Genome Diagnostics Recent Developments
Table 163. Predicine Basic Information
Table 164. Predicine Lung Cancer Liquid Biops Product Overview
Table 165. Predicine Lung Cancer Liquid Biops Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 166. Predicine Business Overview
Table 167. Predicine Recent Developments
Table 168. Global Lung Cancer Liquid Biops Sales Forecast by Region (2026-2033) & (K Units)
Table 169. Global Lung Cancer Liquid Biops Market Size Forecast by Region (2026-2033) & (M USD)
Table 170. North America Lung Cancer Liquid Biops Sales Forecast by Country (2026-2033) & (K Units)
Table 171. North America Lung Cancer Liquid Biops Market Size Forecast by Country (2026-2033) & (M USD)
Table 172. Europe Lung Cancer Liquid Biops Sales Forecast by Country (2026-2033) & (K Units)
Table 173. Europe Lung Cancer Liquid Biops Market Size Forecast by Country (2026-2033) & (M USD)
Table 174. Asia Pacific Lung Cancer Liquid Biops Sales Forecast by Region (2026-2033) & (K Units)
Table 175. Asia Pacific Lung Cancer Liquid Biops Market Size Forecast by Region (2026-2033) & (M USD)
Table 176. South America Lung Cancer Liquid Biops Sales Forecast by Country (2026-2033) & (K Units)
Table 177. South America Lung Cancer Liquid Biops Market Size Forecast by Country (2026-2033) & (M USD)
Table 178. Middle East and Africa Lung Cancer Liquid Biops Sales Forecast by Country (2026-2033) & (Units)
Table 179. Middle East and Africa Lung Cancer Liquid Biops Market Size Forecast by Country (2026-2033) & (M USD)
Table 180. Global Lung Cancer Liquid Biops Sales Forecast by Type (2026-2033) & (K Units)
Table 181. Global Lung Cancer Liquid Biops Market Size Forecast by Type (2026-2033) & (M USD)
Table 182. Global Lung Cancer Liquid Biops Price Forecast by Type (2026-2033) & (USD/Unit)
Table 183. Global Lung Cancer Liquid Biops Sales (K Units) Forecast by Application (2026-2033)
Table 184. Global Lung Cancer Liquid Biops Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Lung Cancer Liquid Biops
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Lung Cancer Liquid Biops Market Size (M USD), 2024-2033
Figure 5. Global Lung Cancer Liquid Biops Market Size (M USD) (2020-2033)
Figure 6. Global Lung Cancer Liquid Biops Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Lung Cancer Liquid Biops Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Lung Cancer Liquid Biops Product Life Cycle
Figure 13. Lung Cancer Liquid Biops Sales Share by Manufacturers in 2024
Figure 14. Global Lung Cancer Liquid Biops Revenue Share by Manufacturers in 2024
Figure 15. Lung Cancer Liquid Biops Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Lung Cancer Liquid Biops Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Lung Cancer Liquid Biops Revenue in 2024
Figure 18. Industry Chain Map of Lung Cancer Liquid Biops
Figure 19. Global Lung Cancer Liquid Biops Market PESTE Analysis
Figure 20. Global Lung Cancer Liquid Biops Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Lung Cancer Liquid Biops Market Share by Type
Figure 27. Sales Market Share of Lung Cancer Liquid Biops by Type (2020-2025)
Figure 28. Sales Market Share of Lung Cancer Liquid Biops by Type in 2024
Figure 29. Market Size Share of Lung Cancer Liquid Biops by Type (2020-2025)
Figure 30. Market Size Share of Lung Cancer Liquid Biops by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Lung Cancer Liquid Biops Market Share by Application
Figure 33. Global Lung Cancer Liquid Biops Sales Market Share by Application (2020-2025)
Figure 34. Global Lung Cancer Liquid Biops Sales Market Share by Application in 2024
Figure 35. Global Lung Cancer Liquid Biops Market Share by Application (2020-2025)
Figure 36. Global Lung Cancer Liquid Biops Market Share by Application in 2024
Figure 37. Global Lung Cancer Liquid Biops Sales Growth Rate by Application (2020-2025)
Figure 38. Global Lung Cancer Liquid Biops Sales Market Share by Region (2020-2025)
Figure 39. Global Lung Cancer Liquid Biops Market Size Market Share by Region (2020-2025)
Figure 40. North America Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Lung Cancer Liquid Biops Sales Market Share by Country in 2024
Figure 43. North America Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Lung Cancer Liquid Biops Market Size Market Share by Country in 2024
Figure 45. U.S. Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Lung Cancer Liquid Biops Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Lung Cancer Liquid Biops Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Lung Cancer Liquid Biops Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Lung Cancer Liquid Biops Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Lung Cancer Liquid Biops Sales Market Share by Country in 2024
Figure 53. Europe Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Lung Cancer Liquid Biops Market Size Market Share by Country in 2024
Figure 55. Germany Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Lung Cancer Liquid Biops Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Lung Cancer Liquid Biops Sales Market Share by Region in 2024
Figure 67. Asia Pacific Lung Cancer Liquid Biops Market Size Market Share by Region in 2024
Figure 68. China Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Lung Cancer Liquid Biops Sales and Growth Rate (K Units)
Figure 79. South America Lung Cancer Liquid Biops Sales Market Share by Country in 2024
Figure 80. South America Lung Cancer Liquid Biops Market Size and Growth Rate (M USD)
Figure 81. South America Lung Cancer Liquid Biops Market Size Market Share by Country in 2024
Figure 82. Brazil Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Lung Cancer Liquid Biops Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Lung Cancer Liquid Biops Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Lung Cancer Liquid Biops Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Lung Cancer Liquid Biops Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Lung Cancer Liquid Biops Production Market Share by Region (2020-2025)
Figure 103. North America Lung Cancer Liquid Biops Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Lung Cancer Liquid Biops Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Lung Cancer Liquid Biops Production (K Units) Growth Rate (2020-2025)
Figure 106. China Lung Cancer Liquid Biops Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Lung Cancer Liquid Biops Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Lung Cancer Liquid Biops Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Lung Cancer Liquid Biops Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Lung Cancer Liquid Biops Market Share Forecast by Type (2026-2033)
Figure 111. Global Lung Cancer Liquid Biops Sales Forecast by Application (2026-2033)
Figure 112. Global Lung Cancer Liquid Biops Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Lung Cancer Liquid Biops
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Lung Cancer Liquid Biops Market Size (M USD), 2024-2033
Figure 5. Global Lung Cancer Liquid Biops Market Size (M USD) (2020-2033)
Figure 6. Global Lung Cancer Liquid Biops Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Lung Cancer Liquid Biops Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Lung Cancer Liquid Biops Product Life Cycle
Figure 13. Lung Cancer Liquid Biops Sales Share by Manufacturers in 2024
Figure 14. Global Lung Cancer Liquid Biops Revenue Share by Manufacturers in 2024
Figure 15. Lung Cancer Liquid Biops Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Lung Cancer Liquid Biops Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Lung Cancer Liquid Biops Revenue in 2024
Figure 18. Industry Chain Map of Lung Cancer Liquid Biops
Figure 19. Global Lung Cancer Liquid Biops Market PESTE Analysis
Figure 20. Global Lung Cancer Liquid Biops Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Lung Cancer Liquid Biops Market Share by Type
Figure 27. Sales Market Share of Lung Cancer Liquid Biops by Type (2020-2025)
Figure 28. Sales Market Share of Lung Cancer Liquid Biops by Type in 2024
Figure 29. Market Size Share of Lung Cancer Liquid Biops by Type (2020-2025)
Figure 30. Market Size Share of Lung Cancer Liquid Biops by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Lung Cancer Liquid Biops Market Share by Application
Figure 33. Global Lung Cancer Liquid Biops Sales Market Share by Application (2020-2025)
Figure 34. Global Lung Cancer Liquid Biops Sales Market Share by Application in 2024
Figure 35. Global Lung Cancer Liquid Biops Market Share by Application (2020-2025)
Figure 36. Global Lung Cancer Liquid Biops Market Share by Application in 2024
Figure 37. Global Lung Cancer Liquid Biops Sales Growth Rate by Application (2020-2025)
Figure 38. Global Lung Cancer Liquid Biops Sales Market Share by Region (2020-2025)
Figure 39. Global Lung Cancer Liquid Biops Market Size Market Share by Region (2020-2025)
Figure 40. North America Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Lung Cancer Liquid Biops Sales Market Share by Country in 2024
Figure 43. North America Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Lung Cancer Liquid Biops Market Size Market Share by Country in 2024
Figure 45. U.S. Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Lung Cancer Liquid Biops Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Lung Cancer Liquid Biops Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Lung Cancer Liquid Biops Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Lung Cancer Liquid Biops Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Lung Cancer Liquid Biops Sales Market Share by Country in 2024
Figure 53. Europe Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Lung Cancer Liquid Biops Market Size Market Share by Country in 2024
Figure 55. Germany Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Lung Cancer Liquid Biops Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Lung Cancer Liquid Biops Sales Market Share by Region in 2024
Figure 67. Asia Pacific Lung Cancer Liquid Biops Market Size Market Share by Region in 2024
Figure 68. China Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Lung Cancer Liquid Biops Sales and Growth Rate (K Units)
Figure 79. South America Lung Cancer Liquid Biops Sales Market Share by Country in 2024
Figure 80. South America Lung Cancer Liquid Biops Market Size and Growth Rate (M USD)
Figure 81. South America Lung Cancer Liquid Biops Market Size Market Share by Country in 2024
Figure 82. Brazil Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Lung Cancer Liquid Biops Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Lung Cancer Liquid Biops Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Lung Cancer Liquid Biops Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Lung Cancer Liquid Biops Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Lung Cancer Liquid Biops Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Lung Cancer Liquid Biops Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Lung Cancer Liquid Biops Production Market Share by Region (2020-2025)
Figure 103. North America Lung Cancer Liquid Biops Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Lung Cancer Liquid Biops Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Lung Cancer Liquid Biops Production (K Units) Growth Rate (2020-2025)
Figure 106. China Lung Cancer Liquid Biops Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Lung Cancer Liquid Biops Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Lung Cancer Liquid Biops Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Lung Cancer Liquid Biops Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Lung Cancer Liquid Biops Market Share Forecast by Type (2026-2033)
Figure 111. Global Lung Cancer Liquid Biops Sales Forecast by Application (2026-2033)
Figure 112. Global Lung Cancer Liquid Biops Market Share Forecast by Application (2026-2033)
